glp 1 shortage The GLP-1 receptor agonist shortage: What you need to know and do FDA says shortage of GLP-1
Description
The gastrointestinal side effect profile is similar but not identical

Efficacy and Limitations Despite the claims, many health experts express skepticism regarding the effectiveness of these GLP-1 supplements for substantial weight loss

Williams A, Morgan J, Johnson A, Bates S, Pople I, Norton S

24 Similarly, it is prudent to prescribe ursodeoxycholic acid during the first year of GLP-1 receptor agonist therapy to prevent gallstone formation

How to Talk to Your Doctor About GLP-1 Weight Loss Drugs Chronic Diseases That GLP-1s Are FDA-Approved to Treat GLP-1s for Heart Disease In March 2024, the FDA approved the GLP-1 drug Wegovy (semaglutide) to treat heart disease in people who are overweight or who have obesity the first approval for a GLP-1 medication outside of diabetes or weight loss
